Date |
Symbol |
Description |
Type |
Disease |
Designation |
Success Rating |
H2 2016
|
ACIU |
|
Phase 1/2 Results |
Neurology |
None |
|
Q4 2017
|
MRUS |
|
Phase 1/2 Results |
Oncology |
None |
|
Q4 2016
|
MBVX |
|
Phase 1 Results |
Oncology |
None |
|
Q4 2016
|
KITE |
|
Phase 1/2 Results |
Oncology |
None |
|
Q4 2016
|
KITE |
|
Phase 1/2 Results |
Oncology |
None |
|
Q3 2017
|
PBYI |
|
PDUFA |
Oncology |
None |
|
Q4 2016
|
HALO |
|
Phase 2 Results |
Oncology |
Fast Track |
|
Q4 2016
|
GALE |
|
Phase 2b Results |
Oncology |
None |
|
Q4 2016
|
FLXN |
|
NDA Submission |
Other |
None |
|
Q4 2016
|
CCXI |
|
Phase 2 Results |
Other |
None |
|